Simplify Logo

Full-Time

Assistant Laboratory Director

Posted on 1/23/2024

Natera

Natera

1,001-5,000 employees

Provides cell-free DNA testing services

Hardware
Biotechnology
Healthcare

Compensation Overview

$121.7k - $152.1kAnnually

Senior

Austin, TX, USA

Category
Lab & Research
Environmental Sciences
Life Sciences
Medical Research
Requirements
  • MD/DO and/or PhD in genetics or related field
  • ABMGG board-certified/eligible in Clinical Cytogenetics and/or Molecular Genetics, ABP board-certified/eligible in Molecular Genetic Pathology or equivalent doctoral-level board preferred
  • Current Certificate of Qualification in Genetic Testing from the NYS CLEP preferred
  • 2 or more years of experience in a CLIA-certified clinical laboratory setting analyzing, interpreting and reporting clinical genetic/genomic data
  • Knowledge of CAP, CLIA, California, and New York state regulations
  • Management experience required
Responsibilities
  • Review, approve, and sign-out reports for a variety of clinical molecular/cytogenetic and/or oncologic results
  • Oversee the review of genetic and CNV variant data
  • Provide clinical and technical support for genetic counselors and other laboratory personnel
  • Set standards for laboratory testing and acceptable levels of analytic performance
  • Analyze lab data and contribute to or write publications for scientific journals
  • May serve as Technical Supervisor ensuring appropriate test method selection and adequate method verification
  • Manage a team by reviewing and approving assigned work, and mentoring and developing staff
  • Work with PHI on a regular basis and complete required training
  • Ensure quality assessment and quality control programs are established and maintained
  • Maintain a current status on Natera training requirements
  • Pass post-offer criminal background check

Natera is a global leader in cell-free DNA testing, specializing in noninvasive tests for fetal, tumor, and donor cfDNA, with a focus on oncology, women's health, and organ health. Their cfDNA technology platform is validated in over 100 peer-reviewed publications, aiming to revolutionize personalized health care decisions.

Company Stage

IPO

Total Funding

$1.2B

Headquarters

Austin, Texas

Founded

2004

Growth & Insights
Headcount

6 month growth

14%

1 year growth

20%

2 year growth

52%

Benefits

Flexible medical plans

Investment options

Time off

Workplace perks

INACTIVE